DocMorris AG (ZRSEF)
USD 39.03
(0.0%)
USD 39.03
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 236.27 Million CHF | -52.09% |
| 2022 | 493.12 Million CHF | -5.16% |
| 2021 | 519.97 Million CHF | -0.02% |
| 2020 | 520.07 Million CHF | 49.12% |
| 2019 | 348.77 Million CHF | 199.66% |
| 2018 | 116.39 Million CHF | 3422.7% |
| 2017 | 3.3 Million CHF | -63.78% |
| 2016 | 9.12 Million CHF | -85.36% |
| 2015 | 62.29 Million CHF | 7.86% |
| 2014 | 57.76 Million CHF | -0.6% |
| 2013 | 58.1 Million CHF | -24.73% |
| 2012 | 77.19 Million CHF | 0.0% |
| 2011 | - CHF | -100.0% |
| 2010 | 6 Million CHF | -20.63% |
| 2009 | 7.56 Million CHF | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 284.18 Million CHF | 34.4% |
| 2024 Q2 | 284.18 Million CHF | 0.0% |
| 2023 Q2 | 361.94 Million CHF | 3.38% |
| 2023 FY | 236.27 Million CHF | -52.09% |
| 2023 Q4 | 236.27 Million CHF | 0.0% |
| 2023 Q3 | 236.27 Million CHF | -34.72% |
| 2023 Q1 | 350.1 Million CHF | -29.0% |
| 2022 Q4 | 493.12 Million CHF | 0.0% |
| 2022 FY | 493.12 Million CHF | -5.16% |
| 2022 Q2 | 518.27 Million CHF | 0.0% |
| 2022 Q3 | 493.12 Million CHF | -4.85% |
| 2022 Q1 | 518.27 Million CHF | -0.33% |
| 2021 Q1 | 521.24 Million CHF | 0.23% |
| 2021 FY | 519.97 Million CHF | -0.02% |
| 2021 Q4 | 519.97 Million CHF | 0.0% |
| 2021 Q3 | 519.97 Million CHF | -0.24% |
| 2021 Q2 | 521.24 Million CHF | 0.0% |
| 2020 FY | 520.07 Million CHF | 49.12% |
| 2020 Q1 | 517.13 Million CHF | 48.27% |
| 2020 Q4 | 520.07 Million CHF | 0.0% |
| 2020 Q2 | 517.13 Million CHF | 0.0% |
| 2020 Q3 | 520.07 Million CHF | 0.57% |
| 2019 Q3 | 348.77 Million CHF | 205.35% |
| 2019 Q4 | 348.77 Million CHF | 0.0% |
| 2019 FY | 348.77 Million CHF | 199.66% |
| 2019 Q1 | 114.22 Million CHF | -1.86% |
| 2019 Q2 | 114.22 Million CHF | 0.0% |
| 2018 Q1 | - CHF | -100.0% |
| 2018 FY | 116.39 Million CHF | 3422.7% |
| 2018 Q4 | 116.39 Million CHF | 0.0% |
| 2018 Q3 | 116.39 Million CHF | 273.57% |
| 2018 Q2 | 31.15 Million CHF | 0.0% |
| 2017 Q1 | - CHF | -100.0% |
| 2017 FY | 3.3 Million CHF | -63.78% |
| 2017 Q4 | 3.3 Million CHF | 0.0% |
| 2017 Q3 | 3.3 Million CHF | -71.6% |
| 2017 Q2 | 11.63 Million CHF | 0.0% |
| 2016 Q1 | - CHF | -100.0% |
| 2016 FY | 9.12 Million CHF | -85.36% |
| 2016 Q4 | 9.12 Million CHF | 0.0% |
| 2016 Q3 | 9.12 Million CHF | 0.0% |
| 2016 Q2 | - CHF | 0.0% |
| 2015 Q3 | 62.29 Million CHF | 0.0% |
| 2015 Q2 | - CHF | 0.0% |
| 2015 FY | 62.29 Million CHF | 7.86% |
| 2015 Q4 | 62.29 Million CHF | 0.0% |
| 2015 Q1 | - CHF | -100.0% |
| 2014 FY | 57.76 Million CHF | -0.6% |
| 2014 Q4 | 57.76 Million CHF | 0.0% |
| 2014 Q3 | 57.76 Million CHF | 0.0% |
| 2014 Q2 | - CHF | 0.0% |
| 2014 Q1 | - CHF | -100.0% |
| 2013 Q2 | - CHF | 0.0% |
| 2013 Q3 | 58.1 Million CHF | 0.0% |
| 2013 Q4 | 58.1 Million CHF | 0.0% |
| 2013 FY | 58.1 Million CHF | -24.73% |
| 2013 Q1 | - CHF | 0.0% |
| 2012 FY | 77.19 Million CHF | 0.0% |
| 2011 FY | - CHF | -100.0% |
| 2010 FY | 6 Million CHF | -20.63% |
| 2009 FY | 7.56 Million CHF | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 312.15 Thousand USD | -75589.633% |
| Allstar Health Brands, Inc. | - USD | -Infinity% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 21.25 Thousand USD | -1111663.599% |
| Café Serendipity Holdings, Inc. | - USD | -Infinity% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 254.07 Thousand USD | -92894.478% |
| HealthWarehouse.com, Inc. | 2.63 Million USD | -8879.83% |
| LIGAND PHARMACEUTICAL INC | 5.75 Million USD | -4005.508% |
| MedGen, Inc. | - USD | -Infinity% |
| Omni Health, Inc. | 495.57 Thousand USD | -47576.047% |
| Oxford Investments Holdings Inc. | - USD | -Infinity% |
| Pineapple, Inc. | - USD | -Infinity% |
| ScripsAmerica, Inc. | 1.06 Million USD | -22006.639% |